Direct Digital Holdings (DRCT) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
4 Feb, 2026Company overview and business model
Operates a full-service advertising and marketing platform, providing ad technology and data-driven campaign optimization for brands, agencies, and middle market businesses across both sell- and buy-side digital advertising ecosystems.
Sell-side business (Colossus SSP) automates ad inventory sales for publishers, offering reach across web, mobile, and connected TV, with a focus on both general and multicultural audiences.
Buy-side business (Orange 142) delivers technology-enabled advertising solutions to clients in sectors like travel, education, energy, healthcare, and financial services, emphasizing small and mid-sized businesses transitioning to digital.
The company completed its IPO in February 2022 and unified its buy-side businesses in October 2024.
Financial performance and metrics
2024 revenue was $62.3 million, down 60% from $157.1 million in 2023, primarily due to a significant sell-side customer pause and lower buy-side activity.
Gross profit for 2024 was $17.4 million (28% margin), compared to $37.6 million (24% margin) in 2023.
Net loss for 2024 was $19.9 million, compared to a net loss of $6.8 million in 2023.
As of September 30, 2025, cash and cash equivalents were $0.9 million, with an accumulated deficit of $16.1 million.
Adjusted EBITDA for 2024 was negative $9.3 million.
Use of proceeds and capital allocation
May receive up to $100 million in gross proceeds from sales of Class A Common Stock to New Circle under the Purchase Agreement.
Net proceeds intended to reduce outstanding debt (if required by debt agreements) and for general corporate purposes, including working capital.
No proceeds from the resale of shares by New Circle; all such proceeds go to the selling stockholder.
Latest events from Direct Digital Holdings
- Executing a turnaround with direct DSP integrations after a 2024 revenue dip.DRCT
Investor presentation10 Feb 2026 - Shelf registration allows up to $400M in securities to fund growth amid ongoing industry risks.DRCT
Registration Filing10 Feb 2026 - Q3 revenue plunged 85% year-over-year, with recovery and liquidity actions underway.DRCT
Q3 202414 Jan 2026 - Revenue dropped 60% in 2024, but margin gains and new initiatives support a 2025 rebound.DRCT
Q4 202426 Dec 2025 - Shareholders to vote on reverse split, major share issuances, and incentive plan expansion.DRCT
Proxy Filing18 Dec 2025 - Shareholders to vote on reverse split, major share issuances, and incentive plan expansion.DRCT
Proxy Filing15 Dec 2025 - Annual meeting to vote on directors, auditor, incentive plan shares, and major share issuance.DRCT
Proxy Filing2 Dec 2025 - Shareholders to vote on increasing authorized shares and issuing up to 50M new shares for capital flexibility.DRCT
Proxy Filing2 Dec 2025 - Board seeks approval for director elections, auditor, incentive plan, and governance amendments.DRCT
Proxy Filing2 Dec 2025